2022 Clinical Updates and Strategies for Use of Cellular Therapy in Current Clinical Practice
Clinical Updates and strategies for use of cellular therapy in current clinical practice
Robert Brian Berryman, MD
December 15, 2022 11:30 – 12:30 pm
Virtual via WebEx
OBJECTIVES: Upon completion of this activity, the participant should be able to:
FACULTY DISCLOSURE: Dr. Brian Berryman is a consultant for Genzyme, GSK and Karyopharm.
PLANNER DISCLOSURE: Dr. John Yaft has no relevant financial relationship to disclose with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Dr. Brian Berryman is a consultant for Genzyme, GSK and Karyopharm.
All relevant financial relationships have been mitigated
Additional Information
Attachment | Size |
---|---|
![]() | 790.49 KB |
![]() | 775.99 KB |
![]() | 439.07 KB |
![]() | 274.42 KB |
![]() | 411.64 KB |
![]() | 2.38 MB |
ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
DESIGNATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Available Credit
- 1.00 AMA PRA Category 1 Credit™The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
- 1.00 Attendance